Revenue (Tables)

3 Months Ended

Mar. 31, 2020

Revenue

Schedule of revenue recognized from collaborative arrangements

	Three Months Ended March 31,
(In thousands)	2020		2019
Janssen	$	6,622	$	5,323
Other		10		15
Total collaboration revenue	$	6,632	$	5,338

Summary of changes in deferred revenue

	Three Months Ended March 31,
(In thousands)	2020		2019
Collaboration revenue recognized in the period from:
Amounts included in deferred revenue at the beginning of the period	$	6,632	$	5,333
Performance obligations satisfied in previous period		—		—

Summary of profit sharing revenue and collaboration loss

	Three Months Ended March 31,
(In thousands)	2020		2019
Mylan collaboration agreement - Amounts receivable from Mylan	$	11,730	$	—
Collaboration loss - Amounts payable to Mylan	$	—	$	1,402

Summary of the reductions to R&D costs related to reimbursement payments

	Three Months Ended March 31,
(In thousands)	2020		2019
Janssen	$	1,207	$	1,411
Mylan		1,271		203
Total reduction to R&D expense	$	2,478	$	1,614